{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:50:03Z","timestamp":1777564203094,"version":"3.51.4"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation","doi-asserted-by":"crossref","award":["No.82270200, No.82070203, No.81770210"],"award-info":[{"award-number":["No.82270200, No.82070203, No.81770210"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation","doi-asserted-by":"crossref","award":["No.82400231"],"award-info":[{"award-number":["No.82400231"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100014103","name":"Key Research and Development Program of Shandong Province","doi-asserted-by":"crossref","award":["No.2018CXGC1213"],"award-info":[{"award-number":["No.2018CXGC1213"]}],"id":[{"id":"10.13039\/100014103","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Academic Promotion Programme of Shandong First Medical University","award":["No. 2019QL018"],"award-info":[{"award-number":["No. 2019QL018"]}]},{"name":"Translational Research Grant of NCRCH","award":["No.2021WWB02, No.2020ZKMB01"],"award-info":[{"award-number":["No.2021WWB02, No.2020ZKMB01"]}]},{"name":"Taishan Scholars Program of Shandong Province"},{"name":"Shandong Provincial Engineering Research Center of Lymphoma"},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"crossref","award":["No. 2023M741506"],"award-info":[{"award-number":["No. 2023M741506"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100007129","name":"Shandong Provincial Natural Science Foundation","doi-asserted-by":"crossref","award":["No. ZR2025MS1193, ZR2023QH193"],"award-info":[{"award-number":["No. ZR2025MS1193, ZR2023QH193"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-03931-z","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T15:26:21Z","timestamp":1762961181000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Proteome-wide mendelian randomization identifies FCRL3 and LY9 as potential therapeutic targets for lymphoma"],"prefix":"10.1007","volume":"16","author":[{"given":"Qianqian","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juanjuan","family":"Shang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingshu","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunfeng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"issue":"10091","key":"3931_CR1","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/S0140-6736(16)32407-2","volume":"390","author":"JO Armitage","year":"2017","unstructured":"Armitage JO, Gascoyne RD, Lunning MA, Cavalli F. Non-Hodgkin lymphoma. Lancet (London England). 2017;390(10091):298\u2013310.","journal-title":"Lancet (London England)"},{"issue":"1","key":"3931_CR2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. Cancer J Clin. 2024;74(1):12\u201349.","journal-title":"Cancer J Clin"},{"issue":"4","key":"3931_CR3","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1056\/NEJMoa011795","volume":"346","author":"B Coiffier","year":"2002","unstructured":"Coiffier B, Lepage E, Briere J, Herbrecht R, Tilly H, Bouabdallah R, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med. 2002;346(4):235\u201342.","journal-title":"N Engl J Med"},{"key":"3931_CR4","doi-asserted-by":"crossref","unstructured":"de Lage P\u00e1duaC, De Vita LA, de Oliveira Alves RN, Jacomassi LB, Culler MD, Reichert HF. CO, Predictors of Survival, treatment Modalities, and clinical outcomes of diffuse large B-Cell lymphoma in patients older than 70 years still an unmet medical need in 2024 based on Real-World evidence. Cancers. 2024;16(8).","DOI":"10.3390\/cancers16081459"},{"issue":"1","key":"3931_CR5","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13045-021-01134-x","volume":"14","author":"Y Liu","year":"2021","unstructured":"Liu Y, Zhou X, Wang X. Targeting the tumor microenvironment in B-cell lymphoma: challenges and opportunities. J Hematol Oncol. 2021;14(1):125.","journal-title":"J Hematol Oncol"},{"key":"3931_CR6","doi-asserted-by":"crossref","unstructured":"Finan C, Gaulton A, Kruger FA, Lumbers RT, Shah T, Engmann J et al. The druggable genome and support for target identification and validation in drug development. Sci Transl Med. 2017;9(383).","DOI":"10.1126\/scitranslmed.aag1166"},{"key":"3931_CR7","doi-asserted-by":"crossref","unstructured":"Yuen S, Phillips TJ, Bannerji R, Marlton P, Gritti G, Seymour JF et al. Polatuzumab vedotin, venetoclax, and an anti-CD20 monoclonal antibody in relapsed\/refractory B-cell non-Hodgkin lymphoma. Am J Hematol. 2024;99(7):1281-9.","DOI":"10.1002\/ajh.27341"},{"issue":"1","key":"3931_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41576-020-0268-2","volume":"22","author":"K Suhre","year":"2021","unstructured":"Suhre K, McCarthy MI, Schwenk JM. Genetics Meets proteomics: perspectives for large population-based studies. Nat Rev Genet. 2021;22(1):19\u201337.","journal-title":"Nat Rev Genet"},{"issue":"8","key":"3931_CR9","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/ng.3314","volume":"47","author":"MR Nelson","year":"2015","unstructured":"Nelson MR, Tipney H, Painter JL, Shen J, Nicoletti P, Shen Y, et al. The support of human genetic evidence for approved drug indications. Nat Genet. 2015;47(8):856\u201360.","journal-title":"Nat Genet"},{"issue":"R1","key":"3931_CR10","doi-asserted-by":"publisher","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","volume":"23","author":"G Davey Smith","year":"2014","unstructured":"Davey Smith G, Hemani G. Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum Mol Genet. 2014;23(R1):R89\u201398.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"3931_CR11","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.1038\/s41467-020-16969-0","volume":"11","author":"AF Schmidt","year":"2020","unstructured":"Schmidt AF, Finan C, Gordillo-Mara\u00f1\u00f3n M, Asselbergs FW, Freitag DF, Patel RS, et al. Genetic drug target validation using Mendelian randomisation. Nat Commun. 2020;11(1):3255.","journal-title":"Nat Commun"},{"issue":"12","key":"3931_CR12","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1038\/s41588-021-00978-w","volume":"53","author":"E Ferkingstad","year":"2021","unstructured":"Ferkingstad E, Sulem P, Atlason BA, Sveinbjornsson G, Magnusson MI, Styrmisdottir EL, et al. Large-scale integration of the plasma proteome with genetics and disease. Nat Genet. 2021;53(12):1712\u201321.","journal-title":"Nat Genet"},{"key":"3931_CR13","doi-asserted-by":"crossref","unstructured":"Pietzner M, Wheeler E, Carrasco-Zanini J, Cortes A, Koprulu M, W\u00f6rheide MA et al. Mapping the proteo-genomic convergence of human diseases. Sci (New York NY).374(6569):eabj1541.","DOI":"10.1126\/science.abj1541"},{"key":"3931_CR14","doi-asserted-by":"publisher","first-page":"k601","DOI":"10.1136\/bmj.k601","volume":"362","author":"NM Davies","year":"2018","unstructured":"Davies NM, Holmes MV, Davey Smith G. Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ (Clinical Res ed). 2018;362:k601.","journal-title":"BMJ (Clinical Res ed)"},{"key":"3931_CR15","doi-asserted-by":"crossref","unstructured":"Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D et al. The MR-Base platform supports systematic causal inference across the human phenome. eLife. 2018;7.","DOI":"10.7554\/eLife.34408"},{"key":"3931_CR16","doi-asserted-by":"crossref","unstructured":"Greco MFD, Minelli C, Sheehan NA, Thompson JRJS. Detecting Pleiotropy in Mendelian randomisation studies with summary data and a continuous outcome. 2015;34(21):2926\u201340.","DOI":"10.1002\/sim.6522"},{"issue":"2","key":"3931_CR17","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J Bowden","year":"2015","unstructured":"Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect Estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44(2):512\u201325.","journal-title":"Int J Epidemiol"},{"issue":"D1","key":"3931_CR18","doi-asserted-by":"publisher","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","volume":"46","author":"DS Wishart","year":"2018","unstructured":"Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, et al. DrugBank 5.0: a major update to the drugbank database for 2018. Nucleic Acids Res. 2018;46(D1):D1074\u201382.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"3931_CR19","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R, et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023;51(D1):D638\u201346.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"3931_CR20","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s13059-019-1758-4","volume":"20","author":"D Otasek","year":"2019","unstructured":"Otasek D, Morris JH, Bou\u00e7as J, Pico AR, Demchak B. Cytoscape automation: empowering workflow-based network analysis. Genome Biol. 2019;20(1):185.","journal-title":"Genome Biol"},{"issue":"1","key":"3931_CR21","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1038\/s41467-017-01261-5","volume":"8","author":"K Watanabe","year":"2017","unstructured":"Watanabe K, Taskesen E, van Bochoven A, Posthuma D. Functional mapping and annotation of genetic associations with FUMA. Nat Commun. 2017;8(1):1826.","journal-title":"Nat Commun"},{"issue":"7877","key":"3931_CR22","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s41586-021-03855-y","volume":"597","author":"Q Wang","year":"2021","unstructured":"Wang Q, Dhindsa RS, Carss K, Harper AR, Nag A, Tachmazidou I, et al. Rare variant contribution to human disease in 281,104 UK biobank exomes. Nature. 2021;597(7877):527\u201332.","journal-title":"Nature"},{"issue":"7982","key":"3931_CR23","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/s41586-023-06547-x","volume":"622","author":"RS Dhindsa","year":"2023","unstructured":"Dhindsa RS, Burren OS, Sun BB, Prins BP, Matelska D, Wheeler E, et al. Rare variant associations with plasma protein levels in the UK biobank. Nature. 2023;622(7982):339\u201347.","journal-title":"Nature"},{"key":"3931_CR24","doi-asserted-by":"crossref","unstructured":"Steen CB, Luca BA, Esfahani MS, Azizi A, Sworder BJ, Nabet BY et al. The landscape of tumor cell states and ecosystems in diffuse large B cell lymphoma. Cancer cell. 2021;39(10):1422-37.e10.","DOI":"10.1016\/j.ccell.2021.08.011"},{"issue":"5","key":"3931_CR25","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nbt.4096","volume":"36","author":"A Butler","year":"2018","unstructured":"Butler A, Hoffman P, Smibert P, Papalexi E, Satija R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat Biotechnol. 2018;36(5):411\u201320.","journal-title":"Nat Biotechnol"},{"issue":"2","key":"3931_CR26","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","volume":"20","author":"D Aran","year":"2019","unstructured":"Aran D, Looney AP, Liu L, Wu E, Fong V, Hsu A, et al. Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat Immunol. 2019;20(2):163\u201372.","journal-title":"Nat Immunol"},{"issue":"18","key":"3931_CR27","first-page":"3069","volume":"31","author":"M Yoo","year":"2015","unstructured":"Yoo M, Shin J, Kim J, Ryall KA, Lee K, Lee S, et al. DSigDB: drug signatures database for gene set analysis. Bioinf (Oxford England). 2015;31(18):3069\u201371.","journal-title":"Bioinf (Oxford England)"},{"key":"3931_CR28","doi-asserted-by":"crossref","unstructured":"Morris GM, Huey R, Olson AJ. Using AutoDock for Ligand-Receptor Docking. Current Protocols in Bioinformatics. 2008;24(1):8.14.1-8.40.","DOI":"10.1002\/0471250953.bi0814s24"},{"issue":"D1","key":"3931_CR29","doi-asserted-by":"publisher","first-page":"D1388","DOI":"10.1093\/nar\/gkaa971","volume":"49","author":"S Kim","year":"2021","unstructured":"Kim S, Chen J, Cheng T, Gindulyte A, He J, He S, et al. PubChem in 2021: new data content and improved web interfaces. Nucleic Acids Res. 2021;49(D1):D1388\u201395.","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"3931_CR30","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1080\/14728222.2018.1472768","volume":"22","author":"D Rostamzadeh","year":"2018","unstructured":"Rostamzadeh D, Kazemi T, Amirghofran Z, Shabani M. Update on Fc receptor-like (FCRL) family: new immunoregulatory players in health and diseases. Expert Opin Ther Targets. 2018;22(6):487\u2013502.","journal-title":"Expert Opin Ther Targets"},{"issue":"17","key":"3931_CR31","doi-asserted-by":"publisher","first-page":"9772","DOI":"10.1073\/pnas.171308498","volume":"98","author":"RS Davis","year":"2001","unstructured":"Davis RS, Wang YH, Kubagawa H, Cooper MD. Identification of a family of Fc receptor homologs with Preferential B cell expression. Proc Natl Acad Sci USA. 2001;98(17):9772\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3931_CR32","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1146\/annurev-immunol-030409-101302","volume":"29","author":"JL Cannons","year":"2011","unstructured":"Cannons JL, Tangye SG, Schwartzberg PL. SLAM family receptors and SAP adaptors in immunity. Annu Rev Immunol. 2011;29:665\u2013705.","journal-title":"Annu Rev Immunol"},{"key":"3931_CR33","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.3389\/fimmu.2018.02661","volume":"9","author":"J Pu\u00f1et-Ortiz","year":"2018","unstructured":"Pu\u00f1et-Ortiz J, S\u00e1ez Moya M, Cuenca M, Caleiras E, Lazaro A, Engel P. Ly9 (CD229) antibody targeting depletes marginal zone and germinal center B cells in lymphoid tissues and reduces salivary gland inflammation in a mouse model of Sj\u00f6gren\u2019s syndrome. Front Immunol. 2018;9:2661.","journal-title":"Front Immunol"},{"key":"3931_CR34","doi-asserted-by":"crossref","unstructured":"Roncador G, Pu\u00f1et-Ortiz J, Maestre L, Rodr\u00edguez-Lobato LG, Jim\u00e9nez S, Reyes-Garc\u00eda AI et al. CD229 (Ly9) a novel biomarker for B-Cell malignancies and multiple myeloma. Cancers. 2022;14(9).","DOI":"10.3390\/cancers14092154"},{"key":"3931_CR35","doi-asserted-by":"crossref","unstructured":"Graham DB, Bell MP, McCausland MM, Huntoon CJ, van Deursen J, Faubion WA et al. Ly9 (CD229)-deficient mice exhibit T cell defects yet do not share several phenotypic characteristics associated with SLAM- and SAP-deficient mice. Journal of immunology (Baltimore, Md: 1950). 2006;176(1):291\u2013300.","DOI":"10.4049\/jimmunol.176.1.291"},{"issue":"9","key":"3931_CR36","doi-asserted-by":"publisher","first-page":"e0239088","DOI":"10.1371\/journal.pone.0239088","volume":"15","author":"Z Bognar","year":"2020","unstructured":"Bognar Z, Cseh AM, Fekete K, Antus C, Bognar R, Tapodi A, et al. Amiodarone\u2019s major metabolite, Desethylamiodarone inhibits proliferation of B16-F10 melanoma cells and limits lung metastasis formation in an in vivo experimental model. PLoS ONE. 2020;15(9):e0239088.","journal-title":"PLoS ONE"},{"key":"3931_CR37","doi-asserted-by":"crossref","unstructured":"Gelman I, Sharma N, McKeeman O, Lee P, Campagna N, Tomei N, et al. The ion channel basis of Pharmacological effects of Amiodarone on myocardial electrophysiological properties, a comprehensive review. Volume 174. Biomedicine & pharmacotherapy\u2009=\u2009Biomedecine & pharmacotherapie; 2024. p. 116513.","DOI":"10.1016\/j.biopha.2024.116513"},{"issue":"3","key":"3931_CR38","first-page":"267","volume":"13","author":"IY Kim","year":"2011","unstructured":"Kim IY, Kang YJ, Yoon MJ, Kim EH, Kim SU, Kwon TK, et al. Amiodarone sensitizes human glioma cells but not astrocytes to TRAIL-induced apoptosis via CHOP-mediated DR5 upregulation. Neurooncology. 2011;13(3):267\u201379.","journal-title":"Neurooncology"},{"issue":"5","key":"3931_CR39","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1093\/eurheartj\/ehad726","volume":"45","author":"G Tsaban","year":"2024","unstructured":"Tsaban G, Ostrovsky D, Alnsasra H, Burrack N, Gordon M, Babayev AS, et al. Amiodarone and pulmonary toxicity in atrial fibrillation: a nationwide Israeli study. Eur Heart J. 2024;45(5):379\u201388.","journal-title":"Eur Heart J"},{"issue":"4","key":"3931_CR40","doi-asserted-by":"publisher","first-page":"420","DOI":"10.2174\/1389450122666210824141044","volume":"23","author":"A Garg","year":"2022","unstructured":"Garg A, Chaturvedi S. A comprehensive review on chrysin: emphasis on molecular Targets, Pharmacological actions and Bio-pharmaceutical aspects. Curr Drug Targets. 2022;23(4):420\u201336.","journal-title":"Curr Drug Targets"},{"key":"3931_CR41","doi-asserted-by":"publisher","first-page":"173763","DOI":"10.1016\/j.ejphar.2020.173763","volume":"892","author":"AAA Salama","year":"2021","unstructured":"Salama AAA, Allam RM. Promising targets of Chrysin and Daidzein in colorectal cancer: Amphiregulin, CXCL1, and MMP-9. Eur J Pharmacol. 2021;892:173763.","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"3931_CR42","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.toxlet.2015.01.008","volume":"233","author":"ER Kasala","year":"2015","unstructured":"Kasala ER, Bodduluru LN, Madana RM, Gogoi VAK, Barua R. Chemopreventive and therapeutic potential of Chrysin in cancer: mechanistic perspectives. Toxicol Lett. 2015;233(2):214\u201325.","journal-title":"Toxicol Lett"},{"key":"3931_CR43","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.phytochem.2017.09.016","volume":"145","author":"R Mani","year":"2018","unstructured":"Mani R, Natesan V. Chrysin: Sources, beneficial Pharmacological activities, and molecular mechanism of action. Phytochemistry. 2018;145:187\u201396.","journal-title":"Phytochemistry"},{"issue":"1","key":"3931_CR44","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41392-023-01689-w","volume":"8","author":"X Liu","year":"2023","unstructured":"Liu X, Zhang X, Shao Z, Zhong X, Ding X, Wu L, et al. Pyrotinib and Chrysin synergistically potentiate autophagy in HER2-positive breast cancer. Signal Transduct Target Therapy. 2023;8(1):463.","journal-title":"Signal Transduct Target Therapy"},{"key":"3931_CR45","doi-asserted-by":"crossref","unstructured":"Gao S, Siddiqui N, Etim I, Du T, Zhang Y, Liang D. Developing nutritional component Chrysin as a therapeutic agent: bioavailability and pharmacokinetics consideration, and ADME mechanisms. Volume 142. Biomedicine & pharmacotherapy\u2009=\u2009Biomedecine & pharmacotherapie; 2021. p. 112080.","DOI":"10.1016\/j.biopha.2021.112080"},{"issue":"20","key":"3931_CR46","doi-asserted-by":"publisher","first-page":"6063","DOI":"10.1111\/febs.16025","volume":"288","author":"A Botvinnik","year":"2021","unstructured":"Botvinnik A, Shivam P, Smith Y, Sharma G, Olshevsky U, Moshel O, et al. APOBEC3G rescues cells from the deleterious effects of DNA damage. FEBS J. 2021;288(20):6063\u201377.","journal-title":"FEBS J"},{"issue":"9","key":"3931_CR47","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/s41556-021-00732-8","volume":"23","author":"G Zhu","year":"2021","unstructured":"Zhu G, Herlyn M, Yang X. TRIM15 and CYLD regulate ERK activation via lysine-63-linked polyubiquitination. Nat Cell Biol. 2021;23(9):978\u201391.","journal-title":"Nat Cell Biol"},{"issue":"9","key":"3931_CR48","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1038\/modpathol.2016.114","volume":"29","author":"X Tian","year":"2016","unstructured":"Tian X, Pelton A, Shahsafaei A, Dorfman DM. Differential expression of enhancer of Zeste homolog 2 (EZH2) protein in small cell and aggressive B-cell non-Hodgkin lymphomas and differential regulation of EZH2 expression by p-ERK1\/2 and MYC in aggressive B-cell lymphomas. Mod Pathology: Official J United States Can Acad Pathol Inc. 2016;29(9):1050\u20137.","journal-title":"Mod Pathology: Official J United States Can Acad Pathol Inc"},{"key":"3931_CR49","doi-asserted-by":"publisher","first-page":"5498054","DOI":"10.1155\/2017\/5498054","volume":"2017","author":"K Anilkumar","year":"2017","unstructured":"Anilkumar K, Reddy GV, Azad R, Yarla NS, Dharmapuri G, Srivastava A, et al. Evaluation of Anti-Inflammatory properties of Isoorientin isolated from tubers of pueraria tuberosa. Oxidative Med Cell Longev. 2017;2017:5498054.","journal-title":"Oxidative Med Cell Longev"},{"key":"3931_CR50","doi-asserted-by":"crossref","unstructured":"Jeong Y, Lee SH, Lee J, Kim MS, Lee YG, Hwang JT et al. Water extract of capsella bursa-pastoris mitigates Doxorubicin-Induced cardiotoxicity by upregulating antioxidant enzymes. Int J Mol Sci. 2023;24(21).","DOI":"10.3390\/ijms242115912"},{"key":"3931_CR51","doi-asserted-by":"crossref","unstructured":"Zhang T, Xiu YH, Xue H, Li YN, Cao JL, Hou WS et al. A mechanism of Isoorientin-Induced apoptosis and migration Inhibition in gastric cancer AGS cells. Pharmaceuticals (Basel Switzerland). 2022;15(12).","DOI":"10.3390\/ph15121541"},{"issue":"11","key":"3931_CR52","first-page":"4861","volume":"15","author":"T Cui","year":"2023","unstructured":"Cui T, Lan Y, Lu Y, Yu F, Lin S, Fu Y, et al. Isoorientin ameliorates H(2)O(2)-induced apoptosis and oxidative stress in chondrocytes by regulating MAPK and PI3K\/Akt pathways. Aging. 2023;15(11):4861\u201374.","journal-title":"Aging"},{"key":"3931_CR53","doi-asserted-by":"publisher","first-page":"175853","DOI":"10.1016\/j.ejphar.2023.175853","volume":"954","author":"S Feng","year":"2023","unstructured":"Feng S, Li Y, Huang H, Huang H, Duan Y, Yuan Z, et al. Isoorientin reverses lung cancer drug resistance by promoting ferroptosis via the SIRT6\/Nrf2\/GPX4 signaling pathway. Eur J Pharmacol. 2023;954:175853.","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"3931_CR54","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.matbio.2007.10.003","volume":"27","author":"SA Kuznetsova","year":"2008","unstructured":"Kuznetsova SA, Mahoney DJ, Martin-Manso G, Ali T, Nentwich HA, Sipes JM, et al. TSG-6 binds via its CUB_C domain to the cell-binding domain of fibronectin and increases fibronectin matrix assembly. Matrix Biology: J Int Soc Matrix Biology. 2008;27(3):201\u201310.","journal-title":"Matrix Biology: J Int Soc Matrix Biology"},{"issue":"10","key":"3931_CR55","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1242\/dev.00422","volume":"130","author":"C F\u00fcl\u00f6p","year":"2003","unstructured":"F\u00fcl\u00f6p C, Sz\u00e1nt\u00f3 S, Mukhopadhyay D, B\u00e1rdos T, Kamath RV, Rugg MS, et al. Impaired cumulus mucification and female sterility in tumor necrosis factor-induced protein-6 deficient mice. Development. 2003;130(10):2253\u201361.","journal-title":"Development"},{"issue":"1","key":"3931_CR56","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1074\/jbc.M112.389874","volume":"288","author":"S Swaidani","year":"2013","unstructured":"Swaidani S, Cheng G, Lauer ME, Sharma M, Mikecz K, Hascall VC, et al. TSG-6 protein is crucial for the development of pulmonary hyaluronan deposition, eosinophilia, and airway hyperresponsiveness in a murine model of asthma. J Biol Chem. 2013;288(1):412\u201322.","journal-title":"J Biol Chem"},{"issue":"5","key":"3931_CR57","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1093\/intimm\/12.5.731","volume":"12","author":"V Kronin","year":"2000","unstructured":"Kronin V, Wu L, Gong S, Nussenzweig MC, Shortman K. DEC-205 as a marker of dendritic cells with regulatory effects on CD8 T cell responses. Int Immunol. 2000;12(5):731\u20135.","journal-title":"Int Immunol"},{"issue":"6","key":"3931_CR58","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1084\/jem.20032220","volume":"199","author":"LC Bonifaz","year":"2004","unstructured":"Bonifaz LC, Bonnyay DP, Charalambous A, Darguste DI, Fujii S, Soares H, et al. In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination. J Exp Med. 2004;199(6):815\u201324.","journal-title":"J Exp Med"},{"issue":"12","key":"3931_CR59","doi-asserted-by":"publisher","first-page":"2918","DOI":"10.1128\/MCB.00131-10","volume":"30","author":"L Voisin","year":"2010","unstructured":"Voisin L, Saba-El-Leil MK, Julien C, Fr\u00e9min C, Meloche S. Genetic demonstration of a redundant role of extracellular signal-regulated kinase 1 (ERK1) and ERK2 mitogen-activated protein kinases in promoting fibroblast proliferation. Mol Cell Biol. 2010;30(12):2918\u201332.","journal-title":"Mol Cell Biol"},{"issue":"4","key":"3931_CR60","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.immuni.2008.02.015","volume":"28","author":"T Yasuda","year":"2008","unstructured":"Yasuda T, Sanjo H, Pag\u00e8s G, Kawano Y, Karasuyama H, Pouyss\u00e9gur J, et al. Erk kinases link pre-B cell receptor signaling to transcriptional events required for early B cell expansion. Immunity. 2008;28(4):499\u2013508.","journal-title":"Immunity"},{"issue":"48","key":"3931_CR61","doi-asserted-by":"publisher","first-page":"18930","DOI":"10.1073\/pnas.0806556105","volume":"105","author":"M Krenz","year":"2008","unstructured":"Krenz M, Gulick J, Osinska HE, Colbert MC, Molkentin JD, Robbins J. Role of ERK1\/2 signaling in congenital valve malformations in Noonan syndrome. Proc Natl Acad Sci USA. 2008;105(48):18930\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"3931_CR62","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.immuni.2005.08.013","volume":"23","author":"AM Fischer","year":"2005","unstructured":"Fischer AM, Katayama CD, Pag\u00e8s G, Pouyss\u00e9gur J, Hedrick SM. The role of erk1 and erk2 in multiple stages of T cell development. Immunity. 2005;23(4):431\u201343.","journal-title":"Immunity"},{"issue":"21","key":"3931_CR63","doi-asserted-by":"publisher","first-page":"9565","DOI":"10.1073\/pnas.92.21.9565","volume":"92","author":"L Robb","year":"1995","unstructured":"Robb L, Drinkwater CC, Metcalf D, Li R, K\u00f6ntgen F, Nicola NA, et al. Hematopoietic and lung abnormalities in mice with a null mutation of the common beta subunit of the receptors for granulocyte-macrophage colony-stimulating factor and interleukins 3 and 5. Proc Natl Acad Sci USA. 1995;92(21):9565\u20139.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03931-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-03931-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-03931-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T17:03:08Z","timestamp":1762966988000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-03931-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3931"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-03931-z","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,12]]},"assertion":[{"value":"21 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study utilizes open-access databases and does not engage in original research involving human participants or animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2098"}}